The applications for novel psychedelic-based combinations, developed with SciSparc, are based on monotherapy and novel combinations of SciSparc’s Cannamide™ and classical psychedelics
‘Neutrality As A Service’: How This Analyst Says Rumble Could Win The Social Media, Video Market
Ahead of its pending merger with CF Acquisition Corp VI (NASDAQ: CFVI), an analyst is calling out Rumble's offering of “neutrality-as-a-service.”